Dexus - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Dexus, formerly Dexus Property Group, is a fully integrated real asset company based in Australasia. Its primary activities include managing a diverse portfolio of real estate and infrastructure assets, including office spaces, industrial properties, retail locations, healthcare facilities, and alternative investments. Dexus also operates a funds management business, offering third-party capital exposure to sector-specific and diversified real asset products. Its products and services cater to a wide range of investors seeking direct exposure to quality real estate and infrastructure assets in Australia. The company serves a broad investor base spanning 23 countries. Dexus is headquartered in Sydney, New South Wales, Australia.
Scope
Detailed information on Dexus required for business and competitor intelligence needs
A study of the major internal and external factors affecting Dexus in the form of a SWOT analysis
An in-depth view of the business model of Dexus including a breakdown and examination of key business segments
Intelligence on Dexus's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
News about Dexus, such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
Gain understanding of Dexus and the factors that influence its strategies.
Track strategic initiatives of the company and latest corporate news and actions.
Assess Dexus as a prospective partner, vendor or supplier.
Support sales activities by understanding your customers' businesses better.
Stay up to date on Dexus's business structure, strategy and prospects.
Company Snapshot
Dexus: Company Overview
Dexus: Overview and Key Facts
Dexus: Overview
Dexus: Key Facts
Dexus: Key Employees
Dexus: Key Employee Biographies
Dexus: Major Products and Services
Dexus: Company History
Dexus: Management Statement
Dexus: Locations and Subsidiaries
Dexus: Key Competitors
Dexus: Company Analysis
Dexus: Business Description
Dexus: SWOT Analysis
Dexus: SWOT Overview
Dexus: Strengths
Dexus: Weaknesses
Dexus: Opportunities
Dexus: Threats
Dexus: Corporate Financial Deals Activity
Dexus: Financial Deals Overview
Dexus: Targets and Partners
Dexus: Top Deals 2020 - 2024YTD*
Dexus: Advisors
Dexus: Top Legal Advisors
Dexus: Top Financial Advisors
Dexus: Mergers and Acquisitions
Dexus: Capital Raising
Dexus: Recent Developments
Dexus: News and Events Summary
Dexus: Business Expansion
Dexus: Contracts
Dexus: Corporate Governance
Dexus: Financial Performance
Dexus: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine
List of Tables
Table 1: Dexus: Key Facts
Table 2: Dexus: Key Employees
Table 3: Dexus: Company History
Table 4: Dexus: Locations and Subsidiaries
Table 5: Dexus: Key Competitors
Table 6: Dexus: Deal Activity by Deal Type - Volume (2020 - YTD*2024)
Table 7: Dexus: M&A Average Deal Size - Value (US$m)
Table 8: Dexus: Targets and Partners
Table 9: Dexus: Top Deals 2020 - 2024YTD*
Table 10: Dexus: Legal Advisor Ranking by Value (US$m)
Table 11: Dexus: Financial Advisor Ranking by Value (US$m)
Table 12: Dexus: M&A Volume and Value Trend (2020 - YTD*2024)
Table 13: Dexus: M&A Activity by Geography (2020 - YTD*2024)
Table 14: Dexus: Capital Raising Volume and Value Trend (2020 - YTD*2024)
Table 15: Dexus: Capital Raising by Deal Type (2020 - YTD*2024)
Table 16: Dexus: News and Events Summary
Table 17: Dexus: Business Expansion
Table 18: Dexus: Contracts
Table 19: Dexus: Corporate Governance
Table 20: Dexus: Financial Performance
Table 21: Dexus: Strategy and Operations
List of Figures
Figure 1: 220 Laboratories Inc: Deal Activity by Deal Type - Volume (2020 - YTD*2024)
Figure 2: 220 Laboratories Inc: Private Equity and Ownership Volume and Value Trend (2020 - YTD*2024)
Figure 3: 220 Laboratories Inc: Private Equity and Ownership Volume by Deal Type (2020 - YTD*2024)